Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis

The in vitro activity of tavaborole, an FDA-approved antifungal drug, was compared to that of four antifungal agents against 170 clinical fungal isolates originating from patients with onychomycosis. Tavaborole had low activity against all isolates compared to itraconazole, terbinafine, and fluconaz...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Abastabar, Mahdi, Haghani, Iman, Shokohi, Tahereh, Hedayati, Mohammad Taghi, Aghili, Seyed Reza, Jedi, Ali, Dadashi, Sulmaz, Shabanzadeh, Shafigheh, Hosseini, Tahereh, Aslani, Narges, Meis, Jacques F., Badali, Hamid
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2018
Teme:
Susceptibility
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256807/
https://ncbi.nlm.nih.gov/pubmed/30224524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01632-18
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items